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Introduction
Aging is often accompanied by a decline in cognitive and 
motor functions and in mental health. Although considered 
part of aging, these conditions may have vitamin B12 deficiency 
(vB12D) as an underlying mechanism. Research on the effect 
of vitamin B12 on brain health has dwindled down as many 
studies reported negative associations between vB12D and 
brain health. However, many patients exhibit broad or minor 
symptoms that leave vB12D undocumented. Additionally, 
laboratory tests to assess vB12D lack sensitivity and specificity 
largely due to absence of a gold standard for diagnosis [1]. In 
fact, many patients with subclinical vB12D exhibit normal 
serum concentration levels. Stereotypically, they are classified 
as asymptomatic based on the classical symptoms of vB12D. 
Additionally, the minimum concentrations of serum vitamin B12 
for optimal neuronal health are not currently known, especially 
for those above the age of 50. If left untreated, vB12D leads 
to irreversible nerve damage and brain atrophy. Therefore, 
mood alteration and cognitive decline (CD) seen in the elderly 
population may be consequences of these changes. Increased 
 
risk of atrophic gastritis, higher prevalence of pernicious 
anemia and increased comorbidities with aging put elderly 
population at a higher risk for vB12D. Serum methylmalonicacid 
(MMA) and homocysteine levels are considered more sensitive 
biomarkers of vB12D than the actual serum levels of the vitamin. 
Classical clinical manifestations of vB12D include megaloblastic 
anemia and neurological dysfunctions. Typically, neurological 
and psychological symptoms of vB12D develop way before 
hematological changes [2]. In the Western world, vB12D is 
mostly linked to malabsorption since the Western diet is a rich 
source of animal food products. However, in the developing 
world vB12D is mostly due to low intake of meat.
Discussion
Vitamin B12
Vitamin B12, also known as cobalamin, is made-up of a corrin 
ring in which a cobalt atom is centrally positioned. Therefore, 
the structurally complex vitamin requires special carriers for 
transport and absorption from the ileum of the small intestine. 
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Salivary and gastric haptocorrins (R-proteins) bind vitamin B12 
with high affinity to protect it from enzymatic degradation. The 
intrinsic factor (IF), which is secreted by the parietal cells of the 
gastric mucosa, aids with its distal absorption. Vitamin B12 is 
transferred to the IF in the intestinal lumen by means of a pH-
dependent process and with the help of pancreatic proteases. 
Additionally, the cannalicular membrane of parietal cells host 
H+/K+ AT Pases or proton pumps that produce hydrochloric acid 
(HCL). Gastric acid assists with release of cobalamin from food 
by denaturing the tertiary and quaternary protein structures. 
Moreover, HCL converts pepsinogen into pepsin to further assist 
with vitamin B12 release from food. 
Conditions that may lead to vitamin B12 deficiency
Cellular aging or senescence decreases organ function 
and ability to repair tissue damage. Consequently, the aging 
gastrointestinal tract experiences structural and functional 
changes that may impact bioavailability of a number of nutrients. 
Vitamin B12 is among those nutrients affected by these 
alterations. In atrophic gastritis, reduced acid production may 
have a pronounced impact on the bioavailability of cobalamin 
due to poor absorption [3]. Additionally, Proton Pump Inhibitors 
(PPIs) reduce the release of IF from parietal cells [3]; therefore, 
prolonged use of PPIs predisposes individuals to vB12D. The 
transfer of vitamin B12 from R-protein to IF requires pancreatic 
enzymatic degradation. Consequently, pancreatic insufficiency 
and chronic pancreatitis may contribute to vB12Das well [4]. 
Vegan and vegetarians are at risk since vitamin B12 is solely 
found in animal food [5]. Other population at risk include 
patients who have undergone vertical sleeve gastrectomy [6] 
or with compromised ileum (Celiac and Crohn’s diseases) [7]. 
Those on metformin, on H2-receptor antagonists [8] or with 
end stage renal disease may also experience vB12D [9]. Alcohol 
drinking [10] and chronological aging [11] add to the etiology. 
Therefore, many conditions and comorbidities that are prevalent 
in elderly predispose to vB12D.
Although cobalamin deficiencies take years to develop, 
patients with compromised absorption are at a higher risk for 
developing the sub-clinical symptoms [12]. In fact, anxiety and 
depressive symptoms have been documented in patients with 
chronic pancreatic diseases [13], PPI use [14], inflammatory 
bowel diseases [15], veganism [16] and in old age. However, 
the majority of reports attribute mental distress to living with 
the disease, and cognitive decline in these patients is usually 
attributed to aging. Nevertheless, a review study described 
that vB12D is linked to anxiety and depressive symptoms [17]. 
Recent report describes that vB12D, as revealed by MMA test 
(nonetheless serum vitamin B12 levels were within a normal 
range), associates with poor cognitive functions after adjusting 
for age, sex, education, apolipoprotein E e4 status, and total 
homocysteine, folate, and creatinine [2]. Many reports describe a 
gradual microstructural integrity loss of the nervous system that 
may induce the sub-clinical symptoms. These tiny alterations are 
not detectable in imaging tests [2,18]. Mechanistically, vitamin 
B12 is a key co-factor for two essential enzymes involved in 
myelin biosynthesis, methionine synthase and L-methylmalonyl-
coenzyme A mutase. However, individual components of 
the myelin sheath have differential turnover rates (ranging 
from 3 weeks to 3 months) which explain the microstructural 
abnormalities associated with vitamin B12 insufficiency. 
Therefore, nerve function may gradually decline as a result of 
loss of myelin integrity. Additionally, age is another factor that 
may alter the turnover rate of myelin biosynthesis [19].
One carbon metabolism and potential epigenetic 
modifications
Vitamin B12 plays a crucial role in the one-carbon metabolism 
pathway (OCMP), which is folate (vitamin B9), vitamin B12 and 
vitamin B6-dependent. OCMP is involved in genomic stability, 
antioxidant enzyme synthesis, DNA methylation, epigenetic 
modification, RNA editing, noncoding RNA, micro RNA. OCMP 
also contributes to metabolism of serotonin, dopamine and 
noradrenaline which are important neurotransmitters to 
support brain and mental health. Derangement of this pathway 
has been linked to abnormal metabolomic profile and increased 
risk for CD and mood alteration among other conditions. 
Epigenetic marks involve covalent modifications of DNA and 
post-translational modifications of histone proteins. Genomic 
DNA of eukaryotic cells (such as in human beings) is organized 
in the form of chromatin which exists on a wide continuum of 
euchromatin and heterochromatin structures. DNA is organized 
around core histone  proteins (H2A, H2B, H3 and H4) forming 
the dynamic nucleosome. histone proteins are positively charged 
at their lysine and arginine residues which induces a favorable 
electrostatic interaction with the negative phosphate backbone 
of DNA. A set of histone and DNA-specific enzymes reprogram 
gene expression repertoire by orchestrating activation 
(acetylation) or repression (methylation) of a cluster of genes 
in response to environmental cues [20]. The OCMP is a source of 
methyl tags that methylate genes. These chemical alterationslead 
to chromatin remodeling which in turn alter the pattern of 
gene expression. Recent evidence suggests that aberrant gene 
expression in key brain regions like the hippocampus and 
prefrontal cortex reduces the ability of the brain to undergo 
neurogenesis and neuroplasticity, respectively. Reports in the 
literature describe that dysregulation of the OCMP associates 
with CD and mental distress; however, some conclusions state 
that the decline is independent of vB12D [21,22] while others 
associate it with CD. Interestingly, the studies that solely 
evaluated serum levels of vitamin B12 reported no link; while 
those that used the more sensitive biomarkers (such as MMA)
reported an association [2,23]. Beside epigenetic modifications, 
disruption of the OCMP leads to hyperhomocysteinemia. 
Homocysteine is a thiol-containing non-protein amino acid that 
is synthetized by transmethylation of methionine in the OCMP. 
Accumulation of Hcy stimulates homocysteinylation of proteins 
where the free thiol group of Hcy forms a disulfide bond with 
another free thiol group derived from a cysteine (Cys) residue 
in a protein molecule. This structural modification alters the 
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overall redox potential of proteins inducing oxidative stress and 
inflammation [24]. The latter have been reported to associate 
with hippocampal atrophy. Adult-induced neurogenesis in the 
hippocampus has been reported to produce robust synaptic 
plasticity which associates with improved cognitive functions 
and a positive mood [25]. Neuroinflammation negatively 
impacts neurogenesis and leads to hippocampal atrophy which 
has been associated with CD and mental distress [13,26]. In fact, 
consumption of dietary antioxidants in older adults associates 
with improved mental wellbeing, which may suggest a higher 
level of oxidative stress in this cohort [27]. Moreover, diets 
high in antioxidants (such as the Mediterranean diet) preserve 
hippocampal volume and reduce CD and mental distress [28].
Conclusion 
Taken collectively, there is a need to re-evaluate the 
function of vitamin B12 in CD and mental health in elderly with 
comorbidities. Standardization of vitamin B12 testing across 
studies may provide a better consensus of the actual role of 
vitamin B12 on cognitive function and mental health across 
populations.
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